The biopsychosocial model is indispensable for comprehending chronic orofacial pain (COP), which is characterized as a non-nociceptive, neuropathic, or nociplastic pain state. Recent research highlights the significant, systemic relationship between psychological factors, specifically psychological distress and reduced self-efficacy/quality of life (QOL), and reported pain intensity [1]. These studies correctly emphasize that a patient’s psychological state often has a greater impact on the prediction of pain severity than diagnostic classification. However, a thorough examination of the research methodologies employed to discern this relationship unveils a critical limitation pertaining to the independence of the measured constructs [2]. When a study utilizes a composite metric, such as the brief pain inventory (BPI) total score, which calculates the mean of both pain severity and pain interference, as the primary outcome, the results may be statistically misleading. The BPI pain interference subscale is, by definition, a measure of reduced function and diminished social engagement. These factors are conceptually inseparable from the psychosocial components identified through techniques such as principal component analysis. Examples of these components include the self-efficacy/QOL component. Future research must either isolate the pain severity subscale or employ structural equation modeling to ensure findings are not methodologically conflated.

In order to resolve this methodological dilemma and advance the biopsychosocial model from mere correlation to mechanistic understanding, it is proposed that objective physiological markers be integrated in a mandatory manner. The brain-heart axis (BHA) provides a non-invasive, objective framework for addressing the biological underpinnings of COP [3]. It utilizes the autonomic nervous system (ANS) as a proxy for the bidirectional communication between the brain and heart.

The extant evidence is largely correlational in nature. In order to establish BHA as a clinical standard, it is necessary to address the factors that influence cardiac intervals independently, as illustrated in Table 2. To determine whether ANS dysregulation precedes COP symptoms, longitudinal studies are required.

In order to establish a connection between theoretical concepts and practical applications, it is recommended that dental practitioners adhere to the following protocol. Initial electrocardiographic screening: In order to establish baseline QTc and HRV levels during the initial assessment, the utilization of medical-grade wearable sensors or a resting 12-lead ECG is imperative. The following is a list of the pharmacological monitoring procedures: It is imperative that practitioners be cognizant of the prevalent interactions between commonly prescribed medications and the BH. The objective of monitoring therapeutic response is to assess the effectiveness of treatment and make adjustments as necessary. The employment of HRV as an objective metric for “physiological recovery” constitutes a pivotal element of this research. An increase in HRV over time has been shown to serve as an objective marker of improved parasympathetic regulation.

Treating a condition driven by NMDA-mediated sensitization and autonomic imbalance necessitates a clinical approach rooted in neurobiology. The incorporation of a robust neuroscience curriculum within the framework of dental education is of paramount importance [15]. This enables practitioners to administer rational pharmacotherapy targeting receptor pathways and elucidate symptoms to patients.

Recent studies have demonstrated a robust correlation between psychological factors and pain intensity in cases of COP. However, the reliability of these findings may be contingent upon the methodological independence of pain outcome measures and psychosocial predictors. In order to surmount this limitation and promote the advancement of the field, it is proposed that there be a shift toward the incorporation of BHA biomarkers, including HRV and QTc analysis, as essential, objective physical markers. This approach anchors the psychological components to concrete, quantifiable physiological dysregulation within the ANS, providing a clear, mechanistic understanding of COP pathogenesis that is rooted in neurochemical (NMDA/dopamine) and brain network (SN/DMN) imbalance. This advancement in research must be paired with a foundational commitment to neuroscience education in advanced dental programs, ultimately strengthening the treatment of COP as a truly evidence-based, systemic neurobiological disorder.